Mirum Pharmaceuticals, Inc. Given Consensus Recommendation of Buy by Brokerages - MarketBeat
MIRM Stock | USD 46.65 1.50 3.32% |
About 51% of Mirum Pharmaceuticals' investor base is interested to short. The analysis of the overall investor sentiment regarding Mirum Pharmaceuticals suggests that many traders are impartial. Mirum Pharmaceuticals' investing sentiment overview a quick insight into current market opportunities from investing in Mirum Pharmaceuticals. Many technical investors use Mirum Pharmaceuticals stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
Mirum |
Mirum Pharmaceuticals, Inc. Given Consensus Recommendation of Buy by Brokerages MarketBeat
Read at news.google.com
Mirum Pharmaceuticals Investor Sentiment by Other News Outlets
Investor sentiment, mood or attitude towards Mirum Pharmaceuticals can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Mirum Pharmaceuticals Fundamental Analysis
We analyze Mirum Pharmaceuticals' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Mirum Pharmaceuticals using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Mirum Pharmaceuticals based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Return On Asset
Return On Asset Comparative Analysis
Mirum Pharmaceuticals is currently under evaluation in return on asset category among its peers. Return on Asset or ROA shows how effective is the management of the company in generating income from utilizing all of the assets at their disposal. It is a useful ratio to evaluate the performance of different departments of a company as well as to understand management performance over time.
Mirum Pharmaceuticals Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Mirum Pharmaceuticals stock to make a market-neutral strategy. Peer analysis of Mirum Pharmaceuticals could also be used in its relative valuation, which is a method of valuing Mirum Pharmaceuticals by comparing valuation metrics with similar companies.
Peers
Mirum Pharmaceuticals Related Equities
XFOR | X4 Pharmaceuticals | 11.43 | ||||
TERN | Terns Pharmaceuticals | 7.82 | ||||
LRMR | Larimar Therapeutics | 7.44 | ||||
AMLX | Amylyx Pharmaceuticals | 5.32 | ||||
APLS | Apellis Pharmaceuticals | 4.63 | ||||
MLTX | MoonLake Immunotherapeuti | 2.65 | ||||
INZY | Inozyme Pharma | 2.64 | ||||
ARQT | Arcutis Biotherapeutics | 1.74 | ||||
DAWN | Day One | 1.33 | ||||
IMCR | Immunocore Holdings | 1.17 | ||||
KALV | Kalvista Pharmaceuticals | 1.10 | ||||
BPMC | Blueprint Medicines | 0.50 | ||||
ABOS | Acumen Pharmaceuticals | 2.65 | ||||
LYRA | Lyra Therapeutics | 5.00 |
Check out Mirum Pharmaceuticals Hype Analysis, Mirum Pharmaceuticals Correlation and Mirum Pharmaceuticals Performance. To learn how to invest in Mirum Stock, please use our How to Invest in Mirum Pharmaceuticals guide.You can also try the Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Mirum Pharmaceuticals. If investors know Mirum will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Mirum Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.08) | Revenue Per Share 6.513 | Quarterly Revenue Growth 0.894 | Return On Assets (0.09) | Return On Equity (0.40) |
The market value of Mirum Pharmaceuticals is measured differently than its book value, which is the value of Mirum that is recorded on the company's balance sheet. Investors also form their own opinion of Mirum Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Mirum Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Mirum Pharmaceuticals' market value can be influenced by many factors that don't directly affect Mirum Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Mirum Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Mirum Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Mirum Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.